2832 total news stories found.
2009-05-06 | Free licenses for CodonCode Aligner, a leading software program for DNA sequence assembly and analysis, will be made available to selected applicants under CodonCode Corporation's new License Grant Program.
2009-05-06 | If taken too late, Tamiflu does little to arrest H1N1 bug and stop spread of virus.
2009-05-05 | Medical researcher/physician Lawrence Broxmeyer MD, lead investigator in a Journal of Infectious Diseases study, has a message for the officials and scientists of WHO and the CDC: There is more to flu-like illness than either "Influenza" or "H1N1".
2009-05-02 | The Web Marketing Association announces the call for entries for its 13th annual WebAward Competition for Web site development at http://www.TheWebAwards.org. The Web Marketing Association will name the Best Pharmaceutical Web site of 2009.
2009-05-02 | BioScience Laboratories received formal approval from the USDA to acquire, house and work with Swine Influenza VR 333 on April 29, 2009.
2009-04-29 | Ultra High Resolution Xradia MicroXCT 3D CT Scanner Provides Insight Into World's Oldest Complete Adult Erect Walking Skeleton
2009-04-27 | Diabetics are always looking to discover new methods and secrets on how they can greatly relieve their diabetic problem - Then, Ranches Hall wanted to share his Secret discovery.
2009-04-24 | Arbour Group participated in the Pharmaceutical and Biotechnology Middle East (PABME) conference and exhibition held at the Dubai World Trade Center on April 20-22, 2009.
2009-04-17 | Norwich Pharmaceuticals, Inc., a perennial leader in contract manufacturing and packaging, has added two more veterans of the industry to top level positions in order to ensure the successful management of its expanded services.
2009-04-17 | Innovive, Inc., the Market leader in single-use rodent caging, is pleased to announce the successful installation of the Innovive System at the new 12,000 cage SPF rodent facility at The Stowers Institute for Medical Research in Kansas City, MO...
2009-04-04 | Digitek is commonly prescribed as a treatment for heart failure and abnormal heart rhythms. If you have been taking Digitek, you should stop immediately and consult your doctor to make sure you have not suffered any adverse side effects from taking this dangerous drug!
2009-03-28 | Drugs with dangerous or deadly side effects often make it into our healthcare system because their potential dangers were unforeseen prior to being released to the general public. These drugs are known as defective drugs.
2009-03-23 | This exciting clinical study news is the best news that we have been waiting on for the past four years to prove the deposition of the medication through Sinus Dynamics.
2009-03-23 | In a recent independent user test of 7 different anti-snoring products on Danish men between the ages of 35 and 50 (and their partners), Asonor - the revolutionary stop snoring nasal spray - walked away as the #1 product overall as well as in price/performance.
2009-03-22 | Dr. Ted Eisenberg, Philadelphia, Pennsylvania cosmetic breast surgeon, authors article on postoperative nausea and vomiting after breast augmentation surgery
2009-03-16 | Now available in the USA, the Mushatt's No. 9 range of medicated creams, ointments and washes are specially formulated for the treatment of Psoriasis and include Psoriasis Skin Ointment, Psoriasis Facial Cream, Psoriasis Scalp Cream, and PsoriWash a non detergent, non foaming Psoriasis wash.
2009-03-14 | StemTech Health Sciences was founded in 2005 in order to bring a new breakthrough product technology to the marketplace. This Product is called StemEnhance and is the beginnings of a natural, phytoceutical dietary supplement.
2009-03-06 | In a recent independent user test of 7 different anti-snoring products on Danish men between the ages of 35 and 50 (and their partners), Asonor - the revolutionary anti-snoring nasal spray - walked away as the #1 product overall as well as in price/performance.
2009-02-25 | The results of a recent survey by BioScience Laboratories to prepare its subject base for upcoming Phase I clinical trials, indicated that 68% of its active subjects pre-qualify for Phase I clinical trials.
2009-02-24 | Norwich Pharmaceuticals can now be experienced online.